vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Repay Holdings Corp (RPAY). Click either name above to swap in a different company.
Repay Holdings Corp is the larger business by last-quarter revenue ($78.6M vs $44.9M, roughly 1.8× AbCellera Biologics Inc.). AbCellera Biologics Inc. runs the higher net margin — -19.9% vs -178.3%, a 158.4% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 0.4%). Repay Holdings Corp produced more free cash flow last quarter ($23.2M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs -1.3%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Repay Holdings Corp is a leading payment technology provider delivering integrated end-to-end payment processing solutions for businesses across North America. Its offerings include credit/debit card processing, ACH transfer services, POS system integrations and digital payment tools, serving retail, healthcare, automotive and e-commerce segments to help clients streamline transaction workflows and boost operational efficiency.
ABCL vs RPAY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $78.6M |
| Net Profit | $-8.9M | $-140.1M |
| Gross Margin | — | 74.2% |
| Operating Margin | -63.7% | -182.2% |
| Net Margin | -19.9% | -178.3% |
| Revenue YoY | 788.4% | 0.4% |
| Net Profit YoY | 73.9% | -3304.1% |
| EPS (diluted) | $-0.03 | $-1.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $78.6M | ||
| Q3 25 | $9.0M | $77.7M | ||
| Q2 25 | $17.1M | $75.6M | ||
| Q1 25 | $4.2M | $77.3M | ||
| Q4 24 | $5.0M | $78.3M | ||
| Q3 24 | $6.5M | $79.1M | ||
| Q2 24 | $7.3M | $74.9M | ||
| Q1 24 | $10.0M | $80.7M |
| Q4 25 | $-8.9M | $-140.1M | ||
| Q3 25 | $-57.1M | $-6.4M | ||
| Q2 25 | $-34.7M | $-102.3M | ||
| Q1 25 | $-45.6M | $-7.9M | ||
| Q4 24 | — | $-4.1M | ||
| Q3 24 | $-51.1M | $3.2M | ||
| Q2 24 | $-36.9M | $-4.1M | ||
| Q1 24 | $-40.6M | $-5.2M |
| Q4 25 | — | 74.2% | ||
| Q3 25 | — | 74.4% | ||
| Q2 25 | — | 75.7% | ||
| Q1 25 | — | 75.9% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 77.8% | ||
| Q2 24 | — | 78.2% | ||
| Q1 24 | — | 76.2% |
| Q4 25 | -63.7% | -182.2% | ||
| Q3 25 | -851.8% | -3.9% | ||
| Q2 25 | -290.2% | -138.7% | ||
| Q1 25 | -1479.6% | -4.7% | ||
| Q4 24 | — | -1.5% | ||
| Q3 24 | -1439.4% | -0.9% | ||
| Q2 24 | -1276.2% | -4.6% | ||
| Q1 24 | -551.5% | -3.1% |
| Q4 25 | -19.9% | -178.3% | ||
| Q3 25 | -637.8% | -8.3% | ||
| Q2 25 | -203.3% | -135.2% | ||
| Q1 25 | -1077.2% | -10.3% | ||
| Q4 24 | — | -5.3% | ||
| Q3 24 | -785.4% | 4.1% | ||
| Q2 24 | -504.3% | -5.4% | ||
| Q1 24 | -408.0% | -6.5% |
| Q4 25 | $-0.03 | $-1.68 | ||
| Q3 25 | $-0.19 | $-0.08 | ||
| Q2 25 | $-0.12 | $-1.15 | ||
| Q1 25 | $-0.15 | $-0.09 | ||
| Q4 24 | — | $-0.04 | ||
| Q3 24 | $-0.17 | $0.03 | ||
| Q2 24 | $-0.13 | $-0.04 | ||
| Q1 24 | $-0.14 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $115.7M |
| Total DebtLower is stronger | — | $280.1M |
| Stockholders' EquityBook value | $966.9M | $484.4M |
| Total Assets | $1.4B | $1.2B |
| Debt / EquityLower = less leverage | — | 0.58× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $115.7M | ||
| Q3 25 | $83.2M | $95.7M | ||
| Q2 25 | $92.4M | $162.6M | ||
| Q1 25 | $159.3M | $165.5M | ||
| Q4 24 | $156.3M | $189.5M | ||
| Q3 24 | $126.6M | $168.7M | ||
| Q2 24 | $148.3M | $147.1M | ||
| Q1 24 | $123.6M | $128.3M |
| Q4 25 | — | $280.1M | ||
| Q3 25 | — | $279.5M | ||
| Q2 25 | — | $279.0M | ||
| Q1 25 | — | $497.6M | ||
| Q4 24 | — | $496.8M | ||
| Q3 24 | — | $496.2M | ||
| Q2 24 | — | $435.6M | ||
| Q1 24 | — | $434.9M |
| Q4 25 | $966.9M | $484.4M | ||
| Q3 25 | $964.0M | $616.9M | ||
| Q2 25 | $1.0B | $633.7M | ||
| Q1 25 | $1.0B | $755.7M | ||
| Q4 24 | $1.1B | $761.3M | ||
| Q3 24 | $1.1B | $754.7M | ||
| Q2 24 | $1.1B | $815.4M | ||
| Q1 24 | $1.1B | $813.8M |
| Q4 25 | $1.4B | $1.2B | ||
| Q3 25 | $1.4B | $1.3B | ||
| Q2 25 | $1.4B | $1.4B | ||
| Q1 25 | $1.3B | $1.5B | ||
| Q4 24 | $1.4B | $1.6B | ||
| Q3 24 | $1.4B | $1.6B | ||
| Q2 24 | $1.4B | $1.5B | ||
| Q1 24 | $1.5B | $1.5B |
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | — | 0.53× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $23.3M |
| Free Cash FlowOCF − Capex | $-44.6M | $23.2M |
| FCF MarginFCF / Revenue | -99.4% | 29.6% |
| Capex IntensityCapex / Revenue | 21.9% | 0.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $90.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $23.3M | ||
| Q3 25 | $-52.6M | $32.2M | ||
| Q2 25 | $-32.4M | $33.1M | ||
| Q1 25 | $-11.6M | $2.5M | ||
| Q4 24 | $-108.6M | $34.3M | ||
| Q3 24 | $-28.9M | $60.1M | ||
| Q2 24 | $-30.0M | $31.0M | ||
| Q1 24 | $-41.7M | $24.8M |
| Q4 25 | $-44.6M | $23.2M | ||
| Q3 25 | $-61.5M | $32.1M | ||
| Q2 25 | $-45.8M | $33.0M | ||
| Q1 25 | $-22.2M | $2.4M | ||
| Q4 24 | $-187.0M | $34.0M | ||
| Q3 24 | $-47.4M | $59.8M | ||
| Q2 24 | $-50.1M | $30.5M | ||
| Q1 24 | $-65.8M | $24.7M |
| Q4 25 | -99.4% | 29.6% | ||
| Q3 25 | -687.0% | 41.3% | ||
| Q2 25 | -267.9% | 43.6% | ||
| Q1 25 | -524.0% | 3.0% | ||
| Q4 24 | -3702.8% | 43.5% | ||
| Q3 24 | -728.4% | 75.6% | ||
| Q2 24 | -683.8% | 40.7% | ||
| Q1 24 | -661.5% | 30.6% |
| Q4 25 | 21.9% | 0.1% | ||
| Q3 25 | 99.7% | 0.2% | ||
| Q2 25 | 78.2% | 0.1% | ||
| Q1 25 | 251.1% | 0.2% | ||
| Q4 24 | 1552.7% | 0.3% | ||
| Q3 24 | 284.6% | 0.3% | ||
| Q2 24 | 274.6% | 0.6% | ||
| Q1 24 | 242.5% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 18.52× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCL
Segment breakdown not available.
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |
